Options Update: Avis Budget Group, Inc. (CAR) & Forest Laboratories (FRX)
CAR ñ Avis Budget Group, Inc.
Shares of the rental car company surged 8% to $9.12 today after the firm posted third-quarter earnings of 54 cents per share. Avis Budget Group reported staggering losses of $9.91 per share in the same period last year. Option players populated the November and December contracts with fresh call trading.
It looks like some 5,100 call options were purchased at the November 10 strike for an average premium of 48 cents apiece. Next, approximately 1,000 calls were coveted at the December 10 strike for 80 cents premium. December contract call-buyers will accrue profits by expiration if shares rise at least 18.5% to surpass the breakeven price of $10.80.
FRX ñ Forest Laboratories
An interesting options strangle combination appears to have been put in place on Tuesday morning with one investor appearing to sell around 3,000 calls at the 30 strike in November and the same amount of puts at the 27.5 strike price also expiring this month. The current share price is $27.75, with the stock rebounding off last weekís $27 low.
The company announced favorable results for its constipation drug, linaclotide, in development with Ironwood Pharma. The 17-day option combination creates a gross premium of 1.10, which implies the investor sees lower volatility going forward in a more favorable post-trial environment. The share price must now remain hemmed between $26.40 and $31.10 for this trade to remain profitable and within the two strike prices in order to see the investor retain the entire premium. Implied volatility is marginally lower at 37.5% today.
Note: The material presented in this commentary is provided forinformational purposes only and is based upon information that isconsidered to be reliable. However, neither Interactive Brokers LLC norits affiliates warrant its completeness, accuracy or adequacy and itshould not be relied upon as such. Neither IB nor its affiliates areresponsible for any errors or omissions or for results obtained fromthe use of this information. Past performance is not necessarilyindicative of future results.
This material is not intended as an offer or solicitation for thepurchase or sale of any security or other financial instrument.Securities or other financial instruments mentioned in this materialare not suitable for all investors. Any opinions expressed herein aregiven in good faith, are subject to change without notice, and are onlycorrect as of the stated date of their issue. The information containedherein does not constitute advice on the tax consequences of making anyparticular investment decision. This material does not take intoaccount your particular investment objectives, financial situations orneeds and is not intended as a recommendation to you of any particularsecurities, financial instruments or strategies. Before investing, youshould consider whether it is suitable for your particularcircumstances and, as necessary, seek professional advice.
View Andrew Wilkinson's post archive >